Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs
• Current interventions may not reflect local drug use practices that lead to HIV risk. • A “common factors” approach can empower providers to develop effective programs. • All NGO-developed interventions in this study reduced drug use-related HIV risks. • This approach can help frontline providers...
Ausführliche Beschreibung
Autor*in: |
Owczarzak, Jill [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2019 |
---|
Schlagwörter: |
---|
Umfang: |
9 |
---|
Übergeordnetes Werk: |
Enthalten in: Statistical analysis to identify biomarkers for safety - Clark, Matthew ELSEVIER, 2018, an international journal on biomedical and psychosocial approaches, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:199 ; year:2019 ; day:1 ; month:06 ; pages:18-26 ; extent:9 |
Links: |
---|
DOI / URN: |
10.1016/j.drugalcdep.2019.02.015 |
---|
Katalog-ID: |
ELV046840885 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV046840885 | ||
003 | DE-627 | ||
005 | 20230624125702.0 | ||
007 | cr uuu---uuuuu | ||
008 | 191021s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.drugalcdep.2019.02.015 |2 doi | |
028 | 5 | 2 | |a GBV00000000000627.pica |
035 | |a (DE-627)ELV046840885 | ||
035 | |a (ELSEVIER)S0376-8716(19)30095-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 15,3 |2 ssgn | ||
084 | |a PHARM |q DE-84 |2 fid | ||
084 | |a 44.38 |2 bkl | ||
084 | |a 44.39 |2 bkl | ||
100 | 1 | |a Owczarzak, Jill |e verfasserin |4 aut | |
245 | 1 | 0 | |a Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs |
264 | 1 | |c 2019 | |
300 | |a 9 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a • Current interventions may not reflect local drug use practices that lead to HIV risk. • A “common factors” approach can empower providers to develop effective programs. • All NGO-developed interventions in this study reduced drug use-related HIV risks. • This approach can help frontline providers respond to local drug use contexts. | ||
650 | 7 | |a Common factors |2 Elsevier | |
650 | 7 | |a Implementation science |2 Elsevier | |
650 | 7 | |a Ukraine |2 Elsevier | |
650 | 7 | |a HIV prevention |2 Elsevier | |
650 | 7 | |a Drug use |2 Elsevier | |
700 | 1 | |a Nguyen, Trang Quynh |4 oth | |
700 | 1 | |a Mazhnaya, Alyona |4 oth | |
700 | 1 | |a Phillips, Sarah D. |4 oth | |
700 | 1 | |a Filippova, Olga |4 oth | |
700 | 1 | |a Alpatova, Polina |4 oth | |
700 | 1 | |a Zub, Tatyana |4 oth | |
700 | 1 | |a Aleksanyan, Ruzanna |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Clark, Matthew ELSEVIER |t Statistical analysis to identify biomarkers for safety |d 2018 |d an international journal on biomedical and psychosocial approaches |g Amsterdam [u.a.] |w (DE-627)ELV000553670 |
773 | 1 | 8 | |g volume:199 |g year:2019 |g day:1 |g month:06 |g pages:18-26 |g extent:9 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.drugalcdep.2019.02.015 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
936 | b | k | |a 44.38 |j Pharmakologie |q VZ |
936 | b | k | |a 44.39 |j Toxikologie |q VZ |
951 | |a AR | ||
952 | |d 199 |j 2019 |b 1 |c 0601 |h 18-26 |g 9 |
author_variant |
j o jo |
---|---|
matchkey_str |
owczarzakjillnguyentrangquynhmazhnayaaly:2019----:ucmeautooaomnatrapoctdvlputrlyalrdipeetoitr |
hierarchy_sort_str |
2019 |
bklnumber |
44.38 44.39 |
publishDate |
2019 |
allfields |
10.1016/j.drugalcdep.2019.02.015 doi GBV00000000000627.pica (DE-627)ELV046840885 (ELSEVIER)S0376-8716(19)30095-X DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Owczarzak, Jill verfasserin aut Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Current interventions may not reflect local drug use practices that lead to HIV risk. • A “common factors” approach can empower providers to develop effective programs. • All NGO-developed interventions in this study reduced drug use-related HIV risks. • This approach can help frontline providers respond to local drug use contexts. Common factors Elsevier Implementation science Elsevier Ukraine Elsevier HIV prevention Elsevier Drug use Elsevier Nguyen, Trang Quynh oth Mazhnaya, Alyona oth Phillips, Sarah D. oth Filippova, Olga oth Alpatova, Polina oth Zub, Tatyana oth Aleksanyan, Ruzanna oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:199 year:2019 day:1 month:06 pages:18-26 extent:9 https://doi.org/10.1016/j.drugalcdep.2019.02.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 199 2019 1 0601 18-26 9 |
spelling |
10.1016/j.drugalcdep.2019.02.015 doi GBV00000000000627.pica (DE-627)ELV046840885 (ELSEVIER)S0376-8716(19)30095-X DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Owczarzak, Jill verfasserin aut Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Current interventions may not reflect local drug use practices that lead to HIV risk. • A “common factors” approach can empower providers to develop effective programs. • All NGO-developed interventions in this study reduced drug use-related HIV risks. • This approach can help frontline providers respond to local drug use contexts. Common factors Elsevier Implementation science Elsevier Ukraine Elsevier HIV prevention Elsevier Drug use Elsevier Nguyen, Trang Quynh oth Mazhnaya, Alyona oth Phillips, Sarah D. oth Filippova, Olga oth Alpatova, Polina oth Zub, Tatyana oth Aleksanyan, Ruzanna oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:199 year:2019 day:1 month:06 pages:18-26 extent:9 https://doi.org/10.1016/j.drugalcdep.2019.02.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 199 2019 1 0601 18-26 9 |
allfields_unstemmed |
10.1016/j.drugalcdep.2019.02.015 doi GBV00000000000627.pica (DE-627)ELV046840885 (ELSEVIER)S0376-8716(19)30095-X DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Owczarzak, Jill verfasserin aut Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Current interventions may not reflect local drug use practices that lead to HIV risk. • A “common factors” approach can empower providers to develop effective programs. • All NGO-developed interventions in this study reduced drug use-related HIV risks. • This approach can help frontline providers respond to local drug use contexts. Common factors Elsevier Implementation science Elsevier Ukraine Elsevier HIV prevention Elsevier Drug use Elsevier Nguyen, Trang Quynh oth Mazhnaya, Alyona oth Phillips, Sarah D. oth Filippova, Olga oth Alpatova, Polina oth Zub, Tatyana oth Aleksanyan, Ruzanna oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:199 year:2019 day:1 month:06 pages:18-26 extent:9 https://doi.org/10.1016/j.drugalcdep.2019.02.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 199 2019 1 0601 18-26 9 |
allfieldsGer |
10.1016/j.drugalcdep.2019.02.015 doi GBV00000000000627.pica (DE-627)ELV046840885 (ELSEVIER)S0376-8716(19)30095-X DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Owczarzak, Jill verfasserin aut Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Current interventions may not reflect local drug use practices that lead to HIV risk. • A “common factors” approach can empower providers to develop effective programs. • All NGO-developed interventions in this study reduced drug use-related HIV risks. • This approach can help frontline providers respond to local drug use contexts. Common factors Elsevier Implementation science Elsevier Ukraine Elsevier HIV prevention Elsevier Drug use Elsevier Nguyen, Trang Quynh oth Mazhnaya, Alyona oth Phillips, Sarah D. oth Filippova, Olga oth Alpatova, Polina oth Zub, Tatyana oth Aleksanyan, Ruzanna oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:199 year:2019 day:1 month:06 pages:18-26 extent:9 https://doi.org/10.1016/j.drugalcdep.2019.02.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 199 2019 1 0601 18-26 9 |
allfieldsSound |
10.1016/j.drugalcdep.2019.02.015 doi GBV00000000000627.pica (DE-627)ELV046840885 (ELSEVIER)S0376-8716(19)30095-X DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Owczarzak, Jill verfasserin aut Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Current interventions may not reflect local drug use practices that lead to HIV risk. • A “common factors” approach can empower providers to develop effective programs. • All NGO-developed interventions in this study reduced drug use-related HIV risks. • This approach can help frontline providers respond to local drug use contexts. Common factors Elsevier Implementation science Elsevier Ukraine Elsevier HIV prevention Elsevier Drug use Elsevier Nguyen, Trang Quynh oth Mazhnaya, Alyona oth Phillips, Sarah D. oth Filippova, Olga oth Alpatova, Polina oth Zub, Tatyana oth Aleksanyan, Ruzanna oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:199 year:2019 day:1 month:06 pages:18-26 extent:9 https://doi.org/10.1016/j.drugalcdep.2019.02.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 199 2019 1 0601 18-26 9 |
language |
English |
source |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:199 year:2019 day:1 month:06 pages:18-26 extent:9 |
sourceStr |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:199 year:2019 day:1 month:06 pages:18-26 extent:9 |
format_phy_str_mv |
Article |
bklname |
Pharmakologie Toxikologie |
institution |
findex.gbv.de |
topic_facet |
Common factors Implementation science Ukraine HIV prevention Drug use |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Statistical analysis to identify biomarkers for safety |
authorswithroles_txt_mv |
Owczarzak, Jill @@aut@@ Nguyen, Trang Quynh @@oth@@ Mazhnaya, Alyona @@oth@@ Phillips, Sarah D. @@oth@@ Filippova, Olga @@oth@@ Alpatova, Polina @@oth@@ Zub, Tatyana @@oth@@ Aleksanyan, Ruzanna @@oth@@ |
publishDateDaySort_date |
2019-01-01T00:00:00Z |
hierarchy_top_id |
ELV000553670 |
dewey-sort |
3610 |
id |
ELV046840885 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV046840885</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624125702.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2019.02.015</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000627.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV046840885</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(19)30095-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Owczarzak, Jill</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Current interventions may not reflect local drug use practices that lead to HIV risk. • A “common factors” approach can empower providers to develop effective programs. • All NGO-developed interventions in this study reduced drug use-related HIV risks. • This approach can help frontline providers respond to local drug use contexts.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Common factors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Implementation science</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ukraine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HIV prevention</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug use</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nguyen, Trang Quynh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mazhnaya, Alyona</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Phillips, Sarah D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Filippova, Olga</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alpatova, Polina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zub, Tatyana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aleksanyan, Ruzanna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:199</subfield><subfield code="g">year:2019</subfield><subfield code="g">day:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:18-26</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2019.02.015</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">199</subfield><subfield code="j">2019</subfield><subfield code="b">1</subfield><subfield code="c">0601</subfield><subfield code="h">18-26</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
author |
Owczarzak, Jill |
spellingShingle |
Owczarzak, Jill ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Common factors Elsevier Implementation science Elsevier Ukraine Elsevier HIV prevention Elsevier Drug use Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs |
authorStr |
Owczarzak, Jill |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000553670 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs Common factors Elsevier Implementation science Elsevier Ukraine Elsevier HIV prevention Elsevier Drug use Elsevier |
topic |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Common factors Elsevier Implementation science Elsevier Ukraine Elsevier HIV prevention Elsevier Drug use |
topic_unstemmed |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Common factors Elsevier Implementation science Elsevier Ukraine Elsevier HIV prevention Elsevier Drug use |
topic_browse |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Common factors Elsevier Implementation science Elsevier Ukraine Elsevier HIV prevention Elsevier Drug use |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
t q n tq tqn a m am s d p sd sdp o f of p a pa t z tz r a ra |
hierarchy_parent_title |
Statistical analysis to identify biomarkers for safety |
hierarchy_parent_id |
ELV000553670 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Statistical analysis to identify biomarkers for safety |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV000553670 |
title |
Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs |
ctrlnum |
(DE-627)ELV046840885 (ELSEVIER)S0376-8716(19)30095-X |
title_full |
Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs |
author_sort |
Owczarzak, Jill |
journal |
Statistical analysis to identify biomarkers for safety |
journalStr |
Statistical analysis to identify biomarkers for safety |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2019 |
contenttype_str_mv |
zzz |
container_start_page |
18 |
author_browse |
Owczarzak, Jill |
container_volume |
199 |
physical |
9 |
class |
610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Owczarzak, Jill |
doi_str_mv |
10.1016/j.drugalcdep.2019.02.015 |
dewey-full |
610 |
title_sort |
outcome evaluation of a “common factors” approach to develop culturally tailored hiv prevention interventions for people who inject drugs |
title_auth |
Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs |
abstract |
• Current interventions may not reflect local drug use practices that lead to HIV risk. • A “common factors” approach can empower providers to develop effective programs. • All NGO-developed interventions in this study reduced drug use-related HIV risks. • This approach can help frontline providers respond to local drug use contexts. |
abstractGer |
• Current interventions may not reflect local drug use practices that lead to HIV risk. • A “common factors” approach can empower providers to develop effective programs. • All NGO-developed interventions in this study reduced drug use-related HIV risks. • This approach can help frontline providers respond to local drug use contexts. |
abstract_unstemmed |
• Current interventions may not reflect local drug use practices that lead to HIV risk. • A “common factors” approach can empower providers to develop effective programs. • All NGO-developed interventions in this study reduced drug use-related HIV risks. • This approach can help frontline providers respond to local drug use contexts. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA |
title_short |
Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs |
url |
https://doi.org/10.1016/j.drugalcdep.2019.02.015 |
remote_bool |
true |
author2 |
Nguyen, Trang Quynh Mazhnaya, Alyona Phillips, Sarah D. Filippova, Olga Alpatova, Polina Zub, Tatyana Aleksanyan, Ruzanna |
author2Str |
Nguyen, Trang Quynh Mazhnaya, Alyona Phillips, Sarah D. Filippova, Olga Alpatova, Polina Zub, Tatyana Aleksanyan, Ruzanna |
ppnlink |
ELV000553670 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth |
doi_str |
10.1016/j.drugalcdep.2019.02.015 |
up_date |
2024-07-06T21:16:23.836Z |
_version_ |
1803865904997466112 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV046840885</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624125702.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2019.02.015</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000627.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV046840885</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(19)30095-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Owczarzak, Jill</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Current interventions may not reflect local drug use practices that lead to HIV risk. • A “common factors” approach can empower providers to develop effective programs. • All NGO-developed interventions in this study reduced drug use-related HIV risks. • This approach can help frontline providers respond to local drug use contexts.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Common factors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Implementation science</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ukraine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HIV prevention</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug use</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nguyen, Trang Quynh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mazhnaya, Alyona</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Phillips, Sarah D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Filippova, Olga</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alpatova, Polina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zub, Tatyana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aleksanyan, Ruzanna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:199</subfield><subfield code="g">year:2019</subfield><subfield code="g">day:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:18-26</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2019.02.015</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">199</subfield><subfield code="j">2019</subfield><subfield code="b">1</subfield><subfield code="c">0601</subfield><subfield code="h">18-26</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
score |
7.401634 |